Literature DB >> 23989933

Peripartum hysterectomy in 38 hospitals in China: a population-based study.

Qiang Wei1, Weiyuan Zhang, Meng Chen, Li Zhang, Guolin He, Xinghui Liu.   

Abstract

OBJECTIVE: To investigate the incidence, indications, risk factors and transfusions of peripartum hysterectomy in China.
METHODS: A population-based study was conducted using inpatient records of 38 hospitals between 1 January 2011 and 31 December 2011; multivariate logistic regression analysis was used to identify independent risk factors for peripartum hysterectomy.
RESULTS: During the study period, there were 43 peripartum hysterectomy cases out of 114,420 deliveries (0.38‰). Abnormal placentation was major indication for peripartum hysterectomy. Several factors significantly increased the risk of peripartum hysterectomy in this population: placenta previa/accreta [adjusted odds ratio (aOR) 49.7, 95 % CI 25.0-98.9], maternal age ≥35 years (aOR 8.1, 95% CI 4.0-16.0), preeclampsia/eclampsia (aOR 7.5, 95% CI 2.6-21.7), cesarean delivery (aOR 3, 95% CI 1.1-8.0), and multiparity (aOR 2.7, 95% CI 1.2-5.4). In contrast, multiple gestations did not.
CONCLUSIONS: Placenta previa/accreta, maternal age ≥35 years, preeclampsia/eclampsia, cesarean delivery and multiparity were risk factors of peripartum hysterectomy.

Entities:  

Mesh:

Year:  2013        PMID: 23989933     DOI: 10.1007/s00404-013-3002-x

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.344


  2 in total

1.  Usefulness of vessel-sealing devices for peripartum hysterectomy: a retrospective cohort study.

Authors:  Diego Rossetti; Salvatore Giovanni Vitale; Giorgio Bogani; Agnese Maria Chiara Rapisarda; Ferdinando Antonio Gulino; Luigi Frigerio
Journal:  Updates Surg       Date:  2015-03-27

Review 2.  Uterine Factor Infertility, a Systematic Review.

Authors:  Camille Sallée; François Margueritte; Pierre Marquet; Pascal Piver; Yves Aubard; Vincent Lavoué; Ludivine Dion; Tristan Gauthier
Journal:  J Clin Med       Date:  2022-08-21       Impact factor: 4.964

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.